An in vitro model based on human primary monocytes for evaluating the effects of engineered nanoparticles on the course of an inflammatory defence reaction. (Abstract/Poster in convegno)

Type
Label
  • An in vitro model based on human primary monocytes for evaluating the effects of engineered nanoparticles on the course of an inflammatory defence reaction. (Abstract/Poster in convegno) (literal)
Anno
  • 2014-01-01T00:00:00+01:00 (literal)
Alternative label
  • Li, Y., P. Italiani, E. Casals, V.F. Puntes, and D. Boraschi. (2014)
    An in vitro model based on human primary monocytes for evaluating the effects of engineered nanoparticles on the course of an inflammatory defence reaction.
    in NANOTOX 2014, 7th International Congress of Nanotoxicology, Antalya (Turkey), April 23-26, 2014
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Li, Y., P. Italiani, E. Casals, V.F. Puntes, and D. Boraschi. (literal)
Note
  • Abstract (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • 1Laboratory of Innate Immunity and Cytokines, Institute of Protein Biochemistry, National Research Council, Napoli, Italy 2Institut Català de Nanotecnologia, Bellaterra, Spain (literal)
Titolo
  • An in vitro model based on human primary monocytes for evaluating the effects of engineered nanoparticles on the course of an inflammatory defence reaction. (literal)
Abstract
  • The possibility that engineered nanoparticles, even in the absence of direct toxicity, may interfere with the normal development of the innate defensive response may cause inadequate immunity and eventual pathological consequences. The possible interference of nanoparticles with the normal development of the innate/inflammatory response was evaluated with an in vitro model based on human primary monocytes, which reliably represents the human inflammatory response. The course of the physiological inflammatory reaction, from initiation and development to eventual resolution, was reproduced by exposing CD14+ human blood monocytes to a sequence of different microenvironmental conditions (CCL2, LPS, TNF?, IFN-?, 37°C vs. 39°C). A parallel culture model was set up, by varying the culture conditions, to mimic persistent pre-pathological inflammation. The effect of endotoxin-free Au nanoparticles (diameter 10 nm, 1.28 ?g/ml, 0.16 cm2/1000000 cells) was assessed on the course of the in vitro inflammatory reaction models. Gene expression and protein production were analysed at different time points for the inflammatory cytokines and receptors IL-1?, IL-1?, IL-1RI, IL-6, IL-18, IL-36? and CCL5, and for the anti-inflammatory factors IL-1Ra, IL-1RII and IL-18BP. Preliminary results show that Au nanoparticles are unable to affect in a significant fashion the course of either the physiological or the persistent inflammatory reaction in the in vitro monocyte-based models, suggesting that these nanoparticles do not alter the innate defensive ability of the human body. We conclude that the use of a valid and representative in vitro model of human inflammation may allow us to realistically investigating the effects of nanoparticles on inflammatory/innate immune responses, thereby being useful to predicting the immunological risk posed by engineered nanomaterials. (literal)
Prodotto di
Autore CNR

Incoming links:


Autore CNR di
Prodotto
data.CNR.it